RUBY PONTELLO: Open Payments
NPI 1538162185 · DARIEN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,903 in 145 payments from 21 companies in 2025. Trend: 2023 $1,699 · 2024 $1,941 · 2025 $2,903
Food & beverage: $2,804Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $534 |
| Neurocrine BioSciences, Inc. | 19 | $459 |
| E.R. Squibb & Sons, L.L.C. | 19 | $420 |
| Janssen Pharmaceuticals, Inc | 17 | $291 |
| Alkermes, Inc. | 18 | $243 |
| Otsuka America Pharmaceutical, Inc. | 6 | $145 |
| Teva Pharmaceuticals USA, Inc. | 4 | $136 |
| Vanda Pharmaceuticals Inc. | 3 | $92 |
| Tris Pharma Inc | 5 | $91 |
| Axsome Therapeutics, Inc. | 3 | $73 |
Products named: VRAYLAR, INGREZZA, COBENFY, ARISTADA, SPRAVATO, INVEGA SUSTENNA, ABILIFY ASIMTUFII, FANAPT.
Industry payments across GA — which companies pay providers there.
